DA Davidson Initiates Coverage On Cellebrite DI with Buy Rating, Announces Price Target of $20

Benzinga Newsdesk www.benzinga.com Neutral 54.6%

Neg 0% Neu 54.6% Pos 0%

DA Davidson analyst Rudy Kessinger initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price Target of $20.